Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  4SC AG    VSC   DE000A14KL72

4SC AG

(VSC)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about 4SC AG
01/154SC AG : First Patient Enrolled in DONIMI Study Evaluating Domatinostat in the N..
EQ
01/094SC AG : 3 upcoming conferences
EQ
01/074SC : enters into avelumab supply agreement with Merck KGaA, Darmstadt, Germany ..
EQ
20194SC AG : Release according to Article 40, Section 1 of the WpHG [the German Secu..
EQ
20194SC AG : Preliminary announcement of the publication of quarterly reports and qu..
EQ
20194SC AG : Preliminary announcement of the publication of financial reports accord..
EQ
20194SC AG : Positive safety review of Phase Ib/II EMERGE study of domatinostat + av..
EQ
20194SC AG : Correction of a release from 19/11/2019 according to Article 40, Sectio..
EQ
20194SC AG : Release according to Article 40, Section 1 of the WpHG [the German Secu..
EQ
20194SC AG : Release according to Article 41 of the WpHG [the German Securities Trad..
EQ
20194SC : secures circa EUR 22.4 million from a capital increase
EQ
20194SC AG : Poster presentation at 1st International Symposium on Merkel Cell Carci..
EQ
20194SC : provides Q3 business update and outlook
EQ
20194SC : and Netherlands Cancer Institute Collaborate on Clinical Evaluation of Dom..
EQ
20194SC AG : Conference call to be hosted on 17 October 2019 to present the Q3 Annou..
EQ
More most relevant news
All news about 4SC AG
01/154SC AG : First Patient Enrolled in DONIMI Study Evaluating Domatinostat in the N..
EQ
01/094SC AG : 3 upcoming conferences
EQ
01/074SC : enters into avelumab supply agreement with Merck KGaA, Darmstadt, Germany ..
EQ
20194SC AG : Release according to Article 40, Section 1 of the WpHG [the German Secu..
EQ
20194SC AG : Preliminary announcement of the publication of quarterly reports and qu..
EQ
20194SC AG : Preliminary announcement of the publication of financial reports accord..
EQ
20194SC AG : Positive safety review of Phase Ib/II EMERGE study of domatinostat + av..
EQ
20194SC AG : Correction of a release from 19/11/2019 according to Article 40, Sectio..
EQ
20194SC AG : Release according to Article 40, Section 1 of the WpHG [the German Secu..
EQ
20194SC AG : Release according to Article 41 of the WpHG [the German Securities Trad..
EQ
More news
News in other languages on 4SC AG
01/154SC AG : Einschluss des ersten Patienten in die DONIMI-Studie mit Domatinostat i..
01/154SC AG : Einschluss des ersten Patienten in die DONIMI-Studie mit Domatinostat i..
01/094SC AG : 3 anstehende Konferenzen
01/094SC AG : 3 anstehende Konferenzen
01/074SC AG schließt Liefervereinbarung mit Merck KGaA, Darmstadt, Germany und Pfi..
01/074SC : schließt Liefervereinbarung mit Merck KGaA, Darmstadt, Germany und Pfizer ..
20194SC AG : Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten V..
20194SC AG : Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und..
20194SC AG : Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß..
20194SC AG : Positive Sicherheitsdaten aus Phase-Ib/II-Studie EMERGE mit Domatinosta..
Press releases
01/154SC AG : First Patient Enrolled in DONIMI Study Evaluating Domatinostat in the N..
EQ
01/094SC AG : 3 upcoming conferences
EQ
01/074SC : enters into avelumab supply agreement with Merck KGaA, Darmstadt, Germany ..
EQ
20194SC AG : Release according to Article 40, Section 1 of the WpHG [the German Secu..
EQ
20194SC AG : Preliminary announcement of the publication of quarterly reports and qu..
EQ
More press releases
Sector news : Biotechnology & Medical Research - NEC
07:17aELI LILLY AND : Lilly, Incyte Say Baricitinib Meets Primary Endpoint in Phase 3 ..
DJ
07:12aAmerica's Gold Giant Bets on Dividends, Improved Mines to Hold Off Rival
DJ
01/22SIERRA ONCOLOGY : Shares Drop 12% Before Reverse Stock Split
DJ
01/22SIERRA ONCOLOGY : Declares 1-for-40 Reverse Stock Split
DJ
01/21FRESENIUS : Kabi Sets up Joint Venture With Bio-Techne, Wilson Wolf
DJ
More sector news : Biotechnology & Medical Research - NEC
Upcoming event on 4SC AG